Advances in Intensity Modulated Proton Therapy for Head and Neck Cancer Treatment
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Head and Neck Oncology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 1254
Special Issue Editor
Interests: intensity modulated proton therapy; proton arc therapy; adaptive proton therapy
Special Issue Information
Dear Colleagues,
Proton therapy can improve the treatment outcomes for patients with head and neck cancer while minimizing the side effects. Moreover, recent advances in proton therapy technology, including image-guided techniques and intensity modulated proton therapy (IMPT), have further enhanced its efficacy and safety in treating head and neck cancer. We encourage submissions that explore the latest research findings in proton therapy for head and neck cancer. Manuscripts may cover topics including, but not limited to, the treatment protocols, patients’ outcomes, comparative studies, technology innovations, and the radiobiological and dosimetric considerations of proton therapy for head and neck cancer.
I look forward to receiving your contributions.
Dr. Suresh Rana
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck cancer
- IMPT
- proton arc
- proton therapy
- clinical outcome
- dosimetry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
